Health & Medical Archives | Be Korea-savvy

Archive by category Health & Medical

Ascom Wins Agreement with IDN Munson Healthcare in the USA

Ascom Wins Agreement with IDN Munson Healthcare in the USA

BAAR, Switzerland, Jan. 16 (Korea Bizwire) — Munson Healthcare, a nine hospital non-profit Integrated Delivery Network (IDN) serving the state of Michigan, selected Ascom (SWX:ASCN.SW), the leading global healthcare Information and Communication Technology (ICT) provider, for a comprehensive technology retrofit of its flagship Munson Medical Center. The CHF 1.1 million agreement signed in the second half [...]

DSM Sinochem Pharmaceuticals Successfully Launches Rosuvastatin Finished Dosage Formulation in Western Europe

DSM Sinochem Pharmaceuticals Successfully Launches Rosuvastatin Finished Dosage Formulation in Western Europe

Rijswijk, Netherlands, Jan. 12 (Korea Bizwire) — Upon patent expiry at the end of December 2017, DSM Sinochem Pharmaceutical (DSP) has successfully launched its fully backward integrated, generic Rosuvastatin drug product in multiple Western European countries. The successful launch will be extended to additional countries prior to the end of January, among which is the [...]

Medibio Announces ISO 13485 Certification

Medibio Announces ISO 13485 Certification

SYDNEY, Australia and MINNEAPOLIS, Jan. 10 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF) has received a Certificate of Compliance certifying that the Company’s Quality Management System complies with the requirements of ISO 13485.  This also includes conformance with the Canadian Medical Device Conformity Assessment System (CMDCAS).  The certification was issued by [...]

Neuralstem to Present at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology

Neuralstem to Present at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology

GERMANTOWN, Md., Jan. 5 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, chief science officer Neuralstem, will present at the Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology at the Marines’ Memorial Club in San Francisco, CA. The presentation is scheduled [...]

Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics

Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics

WALTHAM, Mass., REHOVOT, Israel, and SAN DIEGO, Dec. 22 (Korea Bizwire) — Eloxx Pharmaceuticals Ltd. (“Eloxx”) and Sevion Therapeutics, Inc. (OTCQB:SVON) (“Sevion”) today announced the two companies have completed their previously announced acquisition transaction effective as of December 19, 2017.  The Company will be known as Eloxx Pharmaceuticals, Inc. following the completion of the transaction, and began trading [...]

New Member Appointed to the Board of Directors of Neuralstem

New Member Appointed to the Board of Directors of Neuralstem

GERMANTOWN, Md., Dec. 20 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Xi Chen, Ph.D.,  has been appointed to its Board of Directors, effective immediately. Dr. Chen was appointed by Tianjin to replace Zhang Zhuo as the director appointee of the Series A Convertible [...]

Mayo Clinic to Begin Prospective Clinical Study with Medibio Technology for Expanded Market Opportunities

Mayo Clinic to Begin Prospective Clinical Study with Medibio Technology for Expanded Market Opportunities

SYDNEY, Australia and MINNEAPOLIS, Dec. 14 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions,  is pleased to announce the first prospective clinical trial [...]

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

LONDON, Dec. 5 (Korea Bizwire) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that it intends to sell, subject to market and other conditions, $225 million of American Depositary Shares (“ADSs”) representing ordinary shares of [...]

Neuralstem Presents Positive Updated Data from Phase 2 Study of NSI-189 in Major Depressive Disorder at the 56th American College of Neuropsychopharmacology (ACNP) Annual Meeting

Neuralstem Presents Positive Updated Data from Phase 2 Study of NSI-189 in Major Depressive Disorder at the 56th American College of Neuropsychopharmacology (ACNP) Annual Meeting

GERMANTOWN, Md., Dec. 5 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that additional safety, efficacy and tolerability data from its exploratory Phase 2 clinical trial examining the efficacy of NSI-189 at 40 mg once daily (QD) and 40 mg twice daily (BID) compared to [...]

NTS Ventures and IHMA Announce a Collaborative Agreement to Provide an Extensive Suite of Clinical Mycology, Antifungal and Microbiology Laboratory Services to Support Anti-infective Drug Development to the Biopharmaceutical Industry

NTS Ventures and IHMA Announce a Collaborative Agreement to Provide an Extensive Suite of Clinical Mycology, Antifungal and Microbiology Laboratory Services to Support Anti-infective Drug Development to the Biopharmaceutical Industry

SCHAUMBURG, Ill., Dec. 4 (Korea Bizwire) — NTS Ventures (NTS), a mycology and antifungal clinical research laboratory and International Health Management Associates, Inc./IHMA Europe Sàrl (IHMA), a full-service central clinical microbiology laboratory have announced a non-exclusive collaborative agreement that will provide the pharmaceutical industry with an extensive suite of mycology and antifungal testing services and [...]